Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation

Atherosclerosis

Volumn 148, Issue 1, 2000, Pages 67-73

  Yang, T T C ^a   Koo, M W L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese green tea; Cholesterol; LDL oxidation; Lung Chen Tea; Relative electrophoretic mobility; TBARS

Indexed keywords

CATECHIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID OXIDATION; PRIORITY JOURNAL; TEA; UMBILICAL ARTERY;

CELLS, CULTURED; CHOLESTEROL; CULTURE MEDIA; ELECTROPHORESIS; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; TEA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0033991717     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00239-7     Document Type: Article

References (28)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
2. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
3. Henriksen T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78:1981;6499-6503.
4. Shaish A., Daugherty A., O' Sullivan F., Schonfeld G., Heinecke J.W. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J. Clin. Invest. 96:1995;2075-2082.
5. Bocan T.M.A., Mueller S.B., Brown E.Q., Uhlendorf P.D., Mazur M.J., Newton R.S. Anti-atherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits. Exp. Mol. Pathol. 57:1992;70-83.
6. 2+-mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull. 18:1995;1-4.
7. Salah N., Miller N.J., Paganga G., Tijburg L., Bolwell G.P., Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 322:1995;339-346.
8. Yang T.T.C., Koo M.W.L. Hypocholesterolemic effects of Chinese Tea. Pharmacol. Res. 35:1997;505-512.
9. Serafini M., Ghiselli A., Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nutr. 50:1996;28-32.
10. Liu C.H., Huang M.T., Huang P.C. Sources of triacylglycerol accumulation in livers of rats fed a cholesterol-supplemented diet. Lipids. 30:1995;527-531.
11. Gamble W., Vaughan M., Kruth H.S., Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J. Lipid Res. 19:1978;1068-1070.
12. Havel R.J. Classification of the hyperlipidemias. Annu. Rev. Med. 28:1977;195-209.
13. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
14. Ballantyne F.C. Role of the clinical biochemistry laboratory in the assessment of dyslipoproteinaemias. Ann. Clin. Biochem. 21:1984;166-175.
15. Ho C.T., Chen Q., Shu H., Zhang K.Q., Rosen R.T. Antioxidative effect of polyphenol extract prepared from various Chinese Teas. Prev. Med. 21:1992;520-525.
16. Matsuda H., Chisaka T., Kubomura Y., Yahahara J., Tokunosake, Fujimura H., Kimura H. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J. Ethnopharmacol. 17:1986;213-224.
17. Roeschlau P., Bernt E., Gruber W. Enzymatic determination of total cholesterol in serum. J. Clin. Chem. Biochem. 12:1974;403.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
19. Daniel W.W. Biostatistics: A Foundation for Analysis in the Health Sciences. 5th edn:1991;Wiley, New York.
20. Haberland M.E., Fong D., Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241:1988;215-218.
21. Palinski W., Rosenfeld M.E., Ylä-Herttuala S., Gurther G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.W., Steinberg D., Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
22. Fogelman A.M., Shechter I., Seager J., Hokom M., Child J.S., Edwards P.A. Malondialdehyde alteration of low density lipoprotein leads in cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. USA. 77:1980;2214-2218.
23. Stanton L.W., White R.T., Bryant C.M., Protter A.A., Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267:1992;22446-22451.
24. Mao S.T.J., Yates M.T., Parker R.A., Chi E.M., Jackson R.L. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analog (MDL29,311) that does not lower serum cholesterol. Arterioscler. Thromb. 11:1991;1266-1275.
25. Da Silva E.L., Piskula M., Terao J. Enhancement of antioxidative ability of rat plasma by oral administration of (-)-epicatechin. Free Radic. Biol. Med. 24:1998;1209-1216.
26. Bailey J.M., Makheja A.N., Lee R., Simon T.H. Systemic activation of 15-lipoxygenase in heart, lung, and vascular tissues by hypercholesterolemia: relationship to lipoprotein oxidation and atherogenesis. Atherosclerosis. 113:1995;247-258.
27. Folcik V.A., Nivar-Aristy R.A., Karjewski L.P., Cathcart M.K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96:1995;504-510.
28. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3:1990;77-92.